Silva-Llanes, I., Rodríguez-López, S., González-Naranjo, P., Sastre, E. d., López, M. G., Páez, J. A., . . . Lastres-Becker, I. (2025). Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model.
Citación estilo ChicagoSilva-Llanes, Ignacio, S. Rodríguez-López, Pedro González-Naranjo, E. del Sastre, Manuela G. López, Juan A. Páez, Nuria Campillo, y Isabel Lastres-Becker. Targeting CB2 Receptor With a Novel Antagonist Reverses Cognitive Decline, Neurodegeneration and Pyroptosis in a TAU-dependent Frontotemporal Dementia Mouse Model. 2025.
Cita MLASilva-Llanes, Ignacio, et al. Targeting CB2 Receptor With a Novel Antagonist Reverses Cognitive Decline, Neurodegeneration and Pyroptosis in a TAU-dependent Frontotemporal Dementia Mouse Model. 2025.